• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Concomitant monitoring of WT1 and FLT3-ITD expression in FLT3-ITD acute myeloid leukemia patients: which should we trust as a minimal residual disease marker?

作者信息

De Marchi Federico, Candoni Anna, Zannier Maria Elena, Haley Lisa, Lau Bonnie Wing Yin, Fanin Renato

机构信息

Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.

Department of Pathology, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, MD, 21287, USA.

出版信息

Am J Hematol. 2017 May;92(5):E72-E74. doi: 10.1002/ajh.24686. Epub 2017 Mar 22.

DOI:10.1002/ajh.24686
PMID:28211167
Abstract
摘要

相似文献

1
Concomitant monitoring of WT1 and FLT3-ITD expression in FLT3-ITD acute myeloid leukemia patients: which should we trust as a minimal residual disease marker?FLT3-ITD急性髓系白血病患者中WT1和FLT3-ITD表达的同步监测：作为微小残留病标志物，我们应该相信哪一个？
Am J Hematol. 2017 May;92(5):E72-E74. doi: 10.1002/ajh.24686. Epub 2017 Mar 22.
2
Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia.WT1基因表达对FLT3阳性急性髓系白血病移植前分子微小残留病评估的预测价值
Exp Hematol. 2017 May;49:25-33. doi: 10.1016/j.exphem.2017.01.005. Epub 2017 Feb 1.
3
FLT3 Internal Tandem Duplication Mutation, cMPL and CD34 Expressions Predict Low Survival in Acute Myeloid Leukemia Patients.FLT3内部串联重复突变、cMPL及CD34表达可预测急性髓系白血病患者的低生存率。
Ann Clin Lab Sci. 2016 Dec;46(6):592-600.
4
Wilms' tumor protein and FLT3-internal tandem duplication expression in patients with de novo acute myeloid leukemia.初发急性髓系白血病患者中肾母细胞瘤蛋白和FLT3-内部串联重复的表达
Hematology. 2011 Jan;16(1):37-42. doi: 10.1179/102453311X12902908411913.
5
Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients.在核型正常的急性髓系白血病患者中，使用威尔姆斯瘤1基因表达作为预后和微小残留病监测的可靠标志物。
Clin Lymphoma Myeloma Leuk. 2017 May;17(5):312-319. doi: 10.1016/j.clml.2016.12.006. Epub 2017 Jan 11.
6
Monitoring of WT1 and its target gene IRF8 expression in acute myeloid leukemia and their significance.急性髓系白血病中WT1及其靶基因IRF8表达的监测及其意义。
Int J Lab Hematol. 2015 Aug;37(4):e67-71. doi: 10.1111/ijlh.12309. Epub 2014 Nov 11.
7
Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia.FoxM1 的过表达与急性髓系白血病的不良预后和 FLT3-ITD 相关。
Biochem Biophys Res Commun. 2014 Mar 28;446(1):280-5. doi: 10.1016/j.bbrc.2014.02.094. Epub 2014 Feb 28.
8
Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.基于 FLT3 内部串联重复的成人急性髓细胞白血病微小残留病监测。
Leuk Res. 2012 Mar;36(3):316-23. doi: 10.1016/j.leukres.2011.11.002. Epub 2011 Nov 29.
9
Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.原始粒细胞中CD7的异常表达与伴有FLT3/ITD突变的初发急性髓系白血病高度相关。
Am J Clin Pathol. 2008 Apr;129(4):624-9. doi: 10.1309/NRTX9AKXHR5JBT93.
10
Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples.配对的初发和复发急性髓系白血病样本中FLT3突变的稳定性及预后影响
Leukemia. 2006 Jul;20(7):1217-20. doi: 10.1038/sj.leu.2404246. Epub 2006 Apr 27.

引用本文的文献

1
Gene Mutations, rs16754 Variant, and Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients.基因变异、rs16754 变体及过表达作为急性髓系白血病患者的预后因素
J Clin Med. 2022 Mar 28;11(7):1873. doi: 10.3390/jcm11071873.
2
MRD Tailored Therapy in AML: What We Have Learned So Far.急性髓系白血病中微小残留病定制疗法：我们目前所了解的情况。
Front Oncol. 2021 Jan 15;10:603636. doi: 10.3389/fonc.2020.603636. eCollection 2020.
3
Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma.
抗真菌预防和急性髓细胞白血病的新药：米哚妥林和泊沙康唑的困境。
Ann Hematol. 2020 Jul;99(7):1429-1440. doi: 10.1007/s00277-020-04107-1. Epub 2020 Jun 8.